Rovi sinks on the stock market after presenting results

The Spanish pharmaceutical company Rovi plunges on the stock market by nearly 13% after presenting its quarterly results. The stock, with the pullback, falls below 70 euros. The company has reduced its first-quarter profit by 48%, to €9.4 million, and has cut its forecasts for 2026.